跳至主要内容
临床试验/NCT00139373
NCT00139373Unknown2 期

Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy

Groupe Hospitalier Pitie-Salpetriere2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2005年8月31日最近更新:
适应症
相关药物

试验速览

阶段
2 期
发起方
入组人数
16
试验地点
2

研究概览

简要总结

The syndrome of distractibility is a behavioral disorder induced by a lesion or a dysfunction of the frontal lobe. This sign is frequent in patients with progressive supranuclear palsy (PSP), a neurodegenerative disorder with severe neuronal loss in the prefrontal cortex and cholinergic systems, in particular in the Meynert basalis nucleus. This could participate in the occurrence of the distractibility in these patients. The aim of this study is to evaluate the effect of the donepezil, an anticholinesterase, on the distractibility in PSP patients, by using oculomotor and neuropsychological assessments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with PSP
  • Age > 30 years old
  • Disease duration < 5 years
  • Mini mental state (MMS) > 24
  • Antisaccades %: 40-80%

排除标准

  • Other parkinsonian syndromes
  • MMS < 24

研究者

发起方
Groupe Hospitalier Pitie-Salpetriere
申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Study of the Distractibility Syndrome in Patients... | 临床试验